课题基金 / 基金详情

CDT Compound Semiconductor Physics (PhD Progression 1+3)

CDT Compound Semiconductor Physics (PhD Progression 1+3)
CDT 化合物半导体物理(博士进修 1 3)
批准号:
2881702
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lasers containing Quantum Dot (QD) active regions offer substantial advantages for application in widely tuneable semiconductor lasers, in semiconductor optical amplifiers, in mode-locked lasers and in Photonic Integrated Circuits. In each case the Optimum Epitaxial design is different, albeit based on a common material system and similar physics. Following recent advances made by the Cardiff-UCL team in the design, growth and fabrication of 1300nm emitting QD materials, we see an opportunity to develop epitaxy platforms to support world leading device performance. We have recently demonstrated QD lasers grown by IQE at manufacturing scale on 150mm and 200mm substrates but with considerable variability across the wafer. To make progress we need to understand the origin of the variability, need designs that are insensitive to this variability in the growth, and that are separately optimised for each of the applications above. Alternatively we need on-wafer characterisation that enables the identification of whole wafers or regions of a wafer to be utilised for particular types of device prior to full fabrication. We envisage that close cooperation with material growers and the rest of the team and the development of a very good understanding of the complex relationships between design, growth fabrication and characterisation will be necessary to create a world leading technology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Compound 3K抑制NBS1乳酸化修饰增强DNA损伤克服胃癌化疗耐药的作用及机制研究
  • 批准号:
    2026JJ82336
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    綦湘毅
  • 依托单位:
Compound K促进脂肪细胞棕色化的作用机制研究
  • 批准号:
    22377067
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    鲁春华
  • 依托单位:
靶向FIRΔexon2抑制剂Compound 5a通过激活FBW7抑制结肠癌机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2022
  • 负责人:
    张亚军
  • 依托单位:
β-葡萄糖苷酶高效分泌及催化合成稀有人参皂苷Compound K的机制研究
  • 批准号:
    22108229
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    王盼
  • 依托单位: